## ARE: Alexandria Real Estate Equities, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 -10.9% below STRENGTH zone (3.0-6.0%); PEG 844.20 fails VALUE criteria (<1.0); RSI 27 oversold (REVERSION excluded per A/B test). Stock is in no-man's land without clear edge. Caution: momentum weakening (-12.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($42.07)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 8)

**1. INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alexandria Real Estate Equities**
- Source: Morningstar | 20251204T160932 | Bearish | Relevance: 100%
- Faruqi & Faruqi, LLP is investigating potential securities claims against Alexandria Real Estate Equities (NYSE: ARE) following allegations that the company made misleading statements about its Long Island City property and reported disappointing third-quarter 2025 financial results. Investors who purchased Alexandria securities between January 27, 2025, and October 27, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal options before the January 26, 2026, lead plaintiff deadline. The firm highlights a significant stock price drop after Alexandria's Q3 earnings report, which included missed analyst expectations and declines in revenue, adjusted funds from operation, and occupancy rates.

**2. Alexandria Cuts Dividend Amid Deepening Life Science Strains**
- Source: Yahoo Finance | 20251204T160850 | Bearish | Relevance: 100%
- Alexandria Real Estate Equities (ARE) has significantly cut its dividend by 45% to 72 cents per share for Q4 2025, aiming to boost financial flexibility amidst a challenging life science environment. The company plans to strengthen its balance sheet by disposing of non-core assets, focusing on megacampuses, and reducing capital spending, while repurchasing shares. This move reflects deepening structural pressures in the life science sector and mounting stress on Alexandria's cash flows, leading to a "Strong Sell" rating from Zacks Investment Research.

**3. INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alexandria Real Estate Equities**
- Source: ABC27 | 20251204T104400 | Bearish | Relevance: 100%
- Faruqi & Faruqi, LLP is investigating potential securities claims against Alexandria Real Estate Equities (NYSE: ARE), urging investors who suffered losses between January 27, 2025, and October 27, 2025, to contact them. The investigation stems from allegations that Alexandria made misleading statements regarding its Long Island City property, failed to disclose material adverse facts, and subsequently reported lower-than-expected financial results, causing its stock price to drop over 19% on October 28, 2025. Investors have until January 26, 2026, to seek the role of lead plaintiff in the class action lawsuit.

**4. Alexandria Real Estate Equities, Inc. declares cash dividend of $0.72 per common share for 4Q25**
- Source: MarketScreener | 20251203T140400 | Somewhat-Bullish | Relevance: 100%
- Alexandria Real Estate Equities, Inc. has declared a cash dividend of $0.72 per common share for the fourth quarter of 2025. This news comes amidst various analyst adjustments to price targets for the company, with some maintaining Outperform ratings and others downgrading due to recent financial performance and occupancy challenges. The article also provides key financial data, company profile information, and analyst consensus ratings.

**5. Shareholders who lost money in shares of Alexandria Real Estate Equities, Inc. (NYSE: ARE) Should Contact Wolf Haldenstein Immediately**
- Source: GlobeNewswire | 20251203T133200 | Bearish | Relevance: 100%
- Wolf Haldenstein Adler Freeman & Herz LLP is reminding investors who purchased Alexandria Real Estate Equities, Inc. (NYSE: ARE) between January 27, 2025, and October 27, 2025, that a federal securities class action has been filed. The lawsuit follows disappointing Q3 2025 results, a cut in FFO guidance, a significant real estate impairment charge, and a subsequent dividend reduction, causing a sharp drop in the stock price. Investors have until January 26, 2026, to seek appointment as lead plaintiff.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 6)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Citigroup | $52 | $61 | -15% |
| 2025-12-04 | Evercore ISI Gr | $64 | $72 | -11% |
| 2025-12-04 | BMO Capital | $60 | $67 | -10% |
| 2025-12-04 | Baird | $67 | $73 | -8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Citigroup | main | Neutral |
| 2025-12-04 | Evercore ISI Gr | main | Outperform |
| 2025-12-04 | BMO Capital | main | Outperform |
| 2025-12-04 | Baird | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.14M) |
| Sells | 16 ($4.23M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 3 |

**Top Holders:**
- Vanguard Group Inc: 14.9% (-1.1%)
- Blackrock Inc.: 10.0% (-10.7%)
- State Street Corpora: 6.5% (+3.7%)
- Apg Asset Management: 3.9% (0.0%)
- JPMORGAN CHASE & CO: 3.3% (+34.1%)

### Key Risks

1. Insider selling cluster: $4.2M in recent transactions.
2. Valuation risk: PEG 844.2x with declining EPS estimates leaves no margin for error.
3. Long-term trend broken: trading 39.5% below SMA200.
4. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 844.20 signals overvaluation risk, limited margin of safety. Revenue declining -8% YoY, concerning. Analyst sentiment negative (6 target cuts vs 0 raises). Insider selling cluster ($4.2M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.4B |
| Beta | 1.33 |
| 52W Range | $44.10 - $105.14 |
| Short Interest | 5.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 844.20 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 1.6% to -10.9% (-12.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 13.9pp (needs >3.0% for momentum thesis). Underperforming sector by 8.7pp, stock-specific weakness. Below SMA200 (0.60x), long-term trend not supportive. MACD histogram positive (0.56), confirming momentum. RSI oversold at 27, potential bounce setup. OFD pattern: -MTH (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -10.94% (CS: 0) | Weak |
| RSI_14 | 26.8 | Oversold |
| MACD Histogram | 0.56 | Bullish |
| vs SMA20 | 0.896x | Below |
| vs SMA50 | 0.717x | Below |
| vs SMA200 | 0.605x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $46.59
- **Stop Loss:** $42.07 (9.7% risk)
- **Target:** $51.11 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 110
- **Position Value:** $5,124.90
- **Portfolio %:** 5.12%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-01-26 (Est: $0.42)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.39 | $0.50 | +28.2% |
| 2025Q2 | $0.63 | $0.48 | -24.0% |
| 2025Q1 | $0.60 | $0.51 | -15.5% |
| 2024Q4 | $0.90 | $0.69 | -23.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*